This paper is in the following e-collection/theme issue:

Safety and Error Prevention in Health (202) Reviews on Human Factors (52) Clinical Informatics (1022) Health Services Research (482) Electronic Health Records (1053) ePrescribing and Innovations in Pharmacies (54) Quality Improvement (253) Clinical Communication, Electronic Consultation and Telehealth (590)

Published on in Vol 8, No 4 (2021): Oct-Dec

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/22325, first published .
Including the Reason for Use on Prescriptions Sent to Pharmacists: Scoping Review

Including the Reason for Use on Prescriptions Sent to Pharmacists: Scoping Review

Including the Reason for Use on Prescriptions Sent to Pharmacists: Scoping Review

Authors of this article:

Kathryn Mercer1, 2 Author Orcid Image ;   Caitlin Carter2, 3 Author Orcid Image ;   Catherine Burns1, 4 Author Orcid Image ;   Ryan Tennant1, 4 Author Orcid Image ;   Lisa Guirguis5 Author Orcid Image ;   Kelly Grindrod3 Author Orcid Image
Article Authors Cited by (5) Tweetations (32) Metrics

Journals

  1. Tennant R, Tetui M, Grindrod K, Burns C. Understanding Human Factors Challenges on the Front Lines of Mass COVID-19 Vaccination Clinics: Human Systems Modeling Study. JMIR Human Factors 2022;9(4):e39670 View
  2. Peeters M, Iturrospe E, Jans D, van Nuijs A, De Loof H. Incorporating ‘reason for use’ into the prescribing process of medication: a survey on the opinion of patients in Flanders, Belgium. BMC Health Services Research 2022;22(1) View
  3. Saini S, Leung V, Si E, Ho C, Cheung A, Dalton D, Daneman N, Grindrod K, Ha R, McIsaac W, Oberai A, Schwartz K, Shiamptanis A, Langford B. Documenting the indication for antimicrobial prescribing: a scoping review. BMJ Quality & Safety 2022;31(11):787 View
  4. Schiff G, Lambert B, Wright A. Prescribing medications with indications: time to flip the script. BMJ Quality & Safety 2023;32(6):315 View
  5. Noga F, Hoti E, Ibrahimi E, Toma D, Malaj L. Perceptions and experiences of community pharmacists with off-label prescribing in the pediatric population. International Journal of Pharmacy Practice 2024;32(5):355 View